[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI20125962A - Menetelmä farmaseuttisten substraattien päällystämiseksi - Google Patents

Menetelmä farmaseuttisten substraattien päällystämiseksi

Info

Publication number
FI20125962A
FI20125962A FI20125962A FI20125962A FI20125962A FI 20125962 A FI20125962 A FI 20125962A FI 20125962 A FI20125962 A FI 20125962A FI 20125962 A FI20125962 A FI 20125962A FI 20125962 A FI20125962 A FI 20125962A
Authority
FI
Finland
Prior art keywords
coating pharmaceutical
pharmaceutical substrates
substrates
coating
pharmaceutical
Prior art date
Application number
FI20125962A
Other languages
English (en)
Swedish (sv)
Other versions
FI126168B (fi
Inventor
Pekka Hoppu
Tommi Kääriäinen
Marja-Leena Kääriäinen
Aimo Turunen
Original Assignee
Pekka Hoppu
Tommi Kääriäinen
Marja-Leena Kääriäinen
Aimo Turunen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FI20125962A priority Critical patent/FI126168B/fi
Application filed by Pekka Hoppu, Tommi Kääriäinen, Marja-Leena Kääriäinen, Aimo Turunen filed Critical Pekka Hoppu
Priority to PCT/FI2013/050896 priority patent/WO2014044907A1/en
Priority to JP2015531616A priority patent/JP2015528487A/ja
Priority to US14/428,530 priority patent/US20150250731A1/en
Priority to EP13838806.1A priority patent/EP2897596A4/en
Priority to CN201380048311.9A priority patent/CN104837484A/zh
Publication of FI20125962A publication Critical patent/FI20125962A/fi
Application granted granted Critical
Publication of FI126168B publication Critical patent/FI126168B/fi
Priority to US15/275,900 priority patent/US10603284B2/en
Priority to JP2019071781A priority patent/JP7171494B2/ja
Priority to US16/806,625 priority patent/US11672764B2/en
Priority to US17/978,700 priority patent/US11986559B2/en
Priority to US18/613,671 priority patent/US20240226018A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/22—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the deposition of inorganic material, other than metallic material
    • C23C16/30—Deposition of compounds, mixtures or solid solutions, e.g. borides, carbides, nitrides
    • C23C16/40—Oxides
    • C23C16/403—Oxides of aluminium, magnesium or beryllium
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/22—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the deposition of inorganic material, other than metallic material
    • C23C16/30—Deposition of compounds, mixtures or solid solutions, e.g. borides, carbides, nitrides
    • C23C16/40—Oxides
    • C23C16/405—Oxides of refractory metals or yttrium
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/44—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating
    • C23C16/455—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating characterised by the method used for introducing gases into reaction chamber or for modifying gas flows in reaction chamber
    • C23C16/45523—Pulsed gas flow or change of composition over time
    • C23C16/45525—Atomic layer deposition [ALD]
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/44—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating
    • C23C16/455—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating characterised by the method used for introducing gases into reaction chamber or for modifying gas flows in reaction chamber
    • C23C16/45523—Pulsed gas flow or change of composition over time
    • C23C16/45525—Atomic layer deposition [ALD]
    • C23C16/45555—Atomic layer deposition [ALD] applied in non-semiconductor technology

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Metallurgy (AREA)
  • Mechanical Engineering (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI20125962A 2012-09-18 2012-09-18 Menetelmä farmaseuttisten substraattien päällystämiseksi FI126168B (fi)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FI20125962A FI126168B (fi) 2012-09-18 2012-09-18 Menetelmä farmaseuttisten substraattien päällystämiseksi
JP2015531616A JP2015528487A (ja) 2012-09-18 2013-09-17 医薬品基材のコーティング方法
US14/428,530 US20150250731A1 (en) 2012-09-18 2013-09-17 Method for coating pharmaceutical substrates
EP13838806.1A EP2897596A4 (en) 2012-09-18 2013-09-17 PROCESS FOR COATING PHARMACEUTICAL SUBSTRATES
PCT/FI2013/050896 WO2014044907A1 (en) 2012-09-18 2013-09-17 A method for coating pharmaceutical substrates
CN201380048311.9A CN104837484A (zh) 2012-09-18 2013-09-17 用于涂覆药物基质的方法
US15/275,900 US10603284B2 (en) 2012-09-18 2016-09-26 Method for coating pharmaceutical substrates
JP2019071781A JP7171494B2 (ja) 2012-09-18 2019-04-04 医薬品基材のコーティング方法
US16/806,625 US11672764B2 (en) 2012-09-18 2020-03-02 Method for coating pharmaceutical substrates
US17/978,700 US11986559B2 (en) 2012-09-18 2022-11-01 Method for coating pharmaceutical substrates
US18/613,671 US20240226018A1 (en) 2012-09-18 2024-03-22 Method for coating pharmaceutical substrates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20125962A FI126168B (fi) 2012-09-18 2012-09-18 Menetelmä farmaseuttisten substraattien päällystämiseksi

Publications (2)

Publication Number Publication Date
FI20125962A true FI20125962A (fi) 2014-03-19
FI126168B FI126168B (fi) 2016-07-29

Family

ID=50340624

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20125962A FI126168B (fi) 2012-09-18 2012-09-18 Menetelmä farmaseuttisten substraattien päällystämiseksi

Country Status (6)

Country Link
US (5) US20150250731A1 (fi)
EP (1) EP2897596A4 (fi)
JP (2) JP2015528487A (fi)
CN (1) CN104837484A (fi)
FI (1) FI126168B (fi)
WO (1) WO2014044907A1 (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI126168B (fi) 2012-09-18 2016-07-29 Novaldmedical Ltd Oy Menetelmä farmaseuttisten substraattien päällystämiseksi
KR102371097B1 (ko) 2013-05-24 2022-03-04 나넥사 에이비 무기성 코팅을 갖는 고형의 나노입자
NL2014348B1 (en) * 2015-02-25 2016-10-13 Univ Delft Tech Controlled release from particles encapsulated by molecular layer deposition.
WO2017147318A1 (en) 2016-02-23 2017-08-31 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens
DE102016107760B4 (de) 2016-04-26 2018-09-20 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Essbare Funktionsschichten und Überzüge auf Hybridpolymerbasis für Pharmazie und Lebensmittel
CN108938592A (zh) * 2017-05-26 2018-12-07 武汉艾特米克超能新材料科技有限公司 一种低成本的药物包衣方法
CN107281152A (zh) * 2017-06-19 2017-10-24 武汉艾特米克超能新材料科技有限公司 一种基于ald包覆的药物渗透泵制剂及其制备方法
EP3740197A4 (en) * 2018-01-16 2021-11-10 Applied Materials, Inc. METAL OXIDE ENCAPSULATED DRUG COMPOSITIONS AND METHODS FOR PREPARATION
US11174552B2 (en) 2018-06-12 2021-11-16 Applied Materials, Inc. Rotary reactor for uniform particle coating with thin films
EP3824113A4 (en) 2018-07-19 2022-04-27 Applied Materials, Inc. METHOD AND DEVICE FOR COATING PARTICLES
PT3868366T (pt) * 2018-10-19 2024-03-25 Towa Pharmaceutical Co Ltd Preparação sólida revestida
EP3715499A1 (en) 2019-03-29 2020-09-30 Picosun Oy Substrate coating
TWI738301B (zh) 2019-04-24 2021-09-01 美商應用材料股份有限公司 具有旋轉葉片與氣體注入之用於在固定腔室中塗覆粒子的反應器
TWI732532B (zh) * 2019-04-24 2021-07-01 美商應用材料股份有限公司 用於在具有旋轉槳的固定的腔室中塗覆顆粒的反應器
JP2022530479A (ja) * 2019-04-26 2022-06-29 アプライド マテリアルズ インコーポレイテッド コーティングされた薬物組成物及びその調製方法
GB2585077A (en) 2019-06-28 2020-12-30 Nanexa Ab Apparatus
WO2021041675A1 (en) * 2019-08-27 2021-03-04 Applied Materials, Inc. Vapor phase coatings for pharmaceutical solubility control
US20210059954A1 (en) * 2019-08-27 2021-03-04 Applied Materials, Inc. Vapor Phase Coating Technology for Pharmaceutical Abuse Deterrent Formulations
JP2023511818A (ja) * 2019-12-06 2023-03-23 ナネクサ・アクチボラグ 新規組成物
TW202216124A (zh) * 2020-10-02 2022-05-01 美商應用材料股份有限公司 製備氧化矽塗佈藥品的低溫處理
CN118215470A (zh) * 2021-09-30 2024-06-18 应用材料公司 用于制药应用的低温氧化硅涂层
WO2024033243A1 (en) * 2022-08-10 2024-02-15 Basf Se Process for preparing coated organic particles
WO2024033244A1 (en) * 2022-08-10 2024-02-15 Basf Se Process for preparing coated organic particles
WO2024033246A1 (en) * 2022-08-10 2024-02-15 Basf Se Process for preparing coated organic particles

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289871A (en) 1980-03-27 1981-09-15 Allied Chemical Corporation Method to increase reactor capacity for polycondensation of polyesters
WO1990002546A1 (en) 1988-09-09 1990-03-22 The Ronald T. Dodge Company Pharmaceuticals microencapsulated by vapor deposited polymers and method
US5741505A (en) 1995-01-20 1998-04-21 Mars, Incorporated Edible products having inorganic coatings
US6165512A (en) * 1998-10-30 2000-12-26 Fuisz Technologies Ltd. Dosage forms containing taste masked active agents
US6613383B1 (en) 1999-06-21 2003-09-02 Regents Of The University Of Colorado Atomic layer controlled deposition on particle surfaces
US6713177B2 (en) * 2000-06-21 2004-03-30 Regents Of The University Of Colorado Insulating and functionalizing fine metal-containing particles with conformal ultra-thin films
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
WO2003072089A1 (en) 2002-02-21 2003-09-04 Biovail Laboratories Inc. Controlled release dosage forms
FR2837100B1 (fr) * 2002-03-18 2004-07-23 Flamel Tech Sa Comprimes a bases de microcapsules a liberation modifiee
US7357910B2 (en) 2002-07-15 2008-04-15 Los Alamos National Security, Llc Method for producing metal oxide nanoparticles
EP2596792A1 (en) 2002-10-16 2013-05-29 Takeda Pharmaceutical Company Limited Stable solid preparations
DE10307568B4 (de) 2003-02-22 2007-08-16 ETH-Zürich, Institut für Lebensmittelwissenschaft, Laboratorium für Lebensmittelverfahrenstechnik Verfahren zum Herstellen einer Membran mit Membranlöchern und nach diesem Verfahren hergestellte Mikro-/Nanomembran
JP2004269384A (ja) * 2003-03-06 2004-09-30 Kyowa Hakko Kogyo Co Ltd 吸水性アミノ酸被覆顆粒
US20050058603A1 (en) * 2003-05-02 2005-03-17 Case Western Reserve University Drug delivery system based on polymer nanoshells
JP5062872B2 (ja) * 2003-08-13 2012-10-31 東和薬品株式会社 不快な味を低減した口腔内崩壊錠剤
US8597703B2 (en) * 2005-05-23 2013-12-03 Kraft Foods Global Brands Llc Delivery system for active components as part of an edible composition including a ratio of encapsulating material and active component
EP1621187A1 (en) 2004-07-26 2006-02-01 AstraZeneca AB Pharmaceutical multiparticulate tablet formulations and process for their preparation
JPWO2006090640A1 (ja) * 2005-02-23 2008-07-24 太陽化学株式会社 アミノ酸含有錠剤組成物および錠剤の製造方法
BRPI0614143A2 (pt) 2005-08-02 2012-11-20 Sol Gel Technologies Ltd processo para revestir um material particulado insolével em Água, sàlido, com um àxido metÁlico, material particulado revestido, composiÇço, mÉtodo para o tratamento de uma condiÇço superficial em um induvÍduo, e, uso de material particulado revestido
ES2334933T3 (es) * 2005-08-15 2010-03-17 Siegfried Generics International Ag Comprimido recubierto o granulado que contiene una piridilpirimidina.
US20070280895A1 (en) * 2006-06-02 2007-12-06 Weimer Alan W Coated particles and sunscreen and cosmetic products containing same
US9149564B2 (en) * 2006-06-23 2015-10-06 The Regents Of The University Of California Articles comprising large-surface-area bio-compatible materials and methods for making and using them
JP2008013480A (ja) * 2006-07-05 2008-01-24 Sawai Pharmaceutical Co Ltd 薬物含有微粒子およびその製造方法
GB0616794D0 (en) 2006-08-24 2006-10-04 Arrow Int Ltd Solid dosage form
US9388323B2 (en) 2008-01-18 2016-07-12 Rhodia Operations Latex binders, aqueous coatings and paints having freeze-thaw ability and methods for using same
BRPI0909439A2 (pt) * 2008-03-11 2015-12-15 Takeda Pharmaceutical preparação sólida de desintegração oral, e, método para suprimir a ruptura de grânulos finos
US8524772B2 (en) * 2008-05-09 2013-09-03 Tiara Pharmaceuticals, Inc. Controlled release of N-acetylcysteine (NAC) for reduction of systemic and/or vascular inflammation
JP4706785B2 (ja) 2008-09-30 2011-06-22 アステラス製薬株式会社 経口投与用粒子状医薬組成物
GR20080100696A (el) * 2008-10-23 2010-05-13 Genepharm �.�. Φαρμακοτεχνικη μορφη με βελτιωμενη γευση του φαρμακευτικα αποδεκτου αλατος εσιταλοπραμης
US9090971B2 (en) * 2009-05-11 2015-07-28 The Regents Of The University Of Colorado, A Body Corporate Ultra-thin metal oxide and carbon-metal oxide films prepared by atomic layer deposition (ALD)
JP2013500058A (ja) * 2009-07-24 2013-01-07 ボストン サイエンティフィック サイムド，インコーポレイテッド 原子層堆積によって形成された無機物コーティング層を有する医療装置
ES2611499T3 (es) 2009-12-31 2017-05-09 Sol-Gel Technologies Ltd. Microcápsulas de núcleo estabilizado, procedimiento para su preparación y usos de las mismas
EP2569249B1 (de) 2010-05-14 2017-07-12 Basf Se Verfahren zur einkapselung von metalloxiden mit graphen und die verwendung dieser materialien
WO2011146078A1 (en) 2010-05-21 2011-11-24 Board Of Regents, The University Of Texas System Encapsulated particles for enteric release
JP4803686B2 (ja) 2010-08-31 2011-10-26 協和発酵キリン株式会社 苦味を呈する薬物を含有する顆粒および口腔内崩壊錠
JP2012051810A (ja) * 2010-08-31 2012-03-15 Zensei Yakuhin Kogyo Kk 口腔内崩壊錠およびその製造法
CA2828754A1 (en) 2011-03-03 2012-09-07 Merck Patent Gmbh Coated solid pharmaceutical preparation
EP2680965A2 (de) 2011-03-03 2014-01-08 Umicore AG & Co. KG Katalytisch aktives material und katalysator zur selektiven katalytischen reduktion von stickoxiden
US8936831B2 (en) 2012-02-03 2015-01-20 Uchicago Argonne, Llc Method for fluidizing and coating ultrafine particles, device for fluidizing and coating ultrafine particles
FI126168B (fi) 2012-09-18 2016-07-29 Novaldmedical Ltd Oy Menetelmä farmaseuttisten substraattien päällystämiseksi
KR102371097B1 (ko) 2013-05-24 2022-03-04 나넥사 에이비 무기성 코팅을 갖는 고형의 나노입자
US20170333359A1 (en) 2014-10-20 2017-11-23 Rx Analytic, Inc A drug-containing micro particle
KR101654000B1 (ko) 2015-01-22 2016-09-05 한양대학교 에리카산학협력단 기능성 화장품용 무기분체의 제조방법
KR101796370B1 (ko) 2016-02-05 2017-11-10 경희대학교 산학협력단 황칠 추출물을 포함하는 금속 나노입자의 제조용 조성물 및 이의 이용
EP3740197A4 (en) 2018-01-16 2021-11-10 Applied Materials, Inc. METAL OXIDE ENCAPSULATED DRUG COMPOSITIONS AND METHODS FOR PREPARATION
JP7073924B2 (ja) 2018-06-06 2022-05-24 東京エレクトロン株式会社 原子層成長法を用いて基板上に薄膜を成膜する方法、または装置
TWI732532B (zh) 2019-04-24 2021-07-01 美商應用材料股份有限公司 用於在具有旋轉槳的固定的腔室中塗覆顆粒的反應器
JP2022530479A (ja) 2019-04-26 2022-06-29 アプライド マテリアルズ インコーポレイテッド コーティングされた薬物組成物及びその調製方法
WO2021041675A1 (en) 2019-08-27 2021-03-04 Applied Materials, Inc. Vapor phase coatings for pharmaceutical solubility control
TW202211911A (zh) 2020-06-05 2022-04-01 美商應用材料股份有限公司 經塗佈的藥物組成物及製備彼之方法
TW202216124A (zh) 2020-10-02 2022-05-01 美商應用材料股份有限公司 製備氧化矽塗佈藥品的低溫處理
WO2023215312A1 (en) 2022-05-03 2023-11-09 Applied Materials, Inc. Drug compositions and methods of preparing the same
WO2023215472A1 (en) 2022-05-06 2023-11-09 Applied Materials, Inc. Ozone-based low temperature silicon oxide coating for pharmaceutical applications

Also Published As

Publication number Publication date
JP7171494B2 (ja) 2022-11-15
US20150250731A1 (en) 2015-09-10
US20240226018A1 (en) 2024-07-11
US20230059964A1 (en) 2023-02-23
WO2014044907A1 (en) 2014-03-27
US10603284B2 (en) 2020-03-31
EP2897596A1 (en) 2015-07-29
JP2019104763A (ja) 2019-06-27
US20200197313A1 (en) 2020-06-25
FI126168B (fi) 2016-07-29
US11986559B2 (en) 2024-05-21
US11672764B2 (en) 2023-06-13
EP2897596A4 (en) 2016-06-29
JP2015528487A (ja) 2015-09-28
US20170007545A1 (en) 2017-01-12
CN104837484A (zh) 2015-08-12

Similar Documents

Publication Publication Date Title
FI20125962A (fi) Menetelmä farmaseuttisten substraattien päällystämiseksi
FI20125358A (fi) Menetelmä ligniinin reaktiivisuuden lisäämiseksi
FI20125146A (fi) Selluloosamassan esikäsittelymenetelmä
FI20116048A (fi) Menetelmä NFC-kalvojen valmistamiseksi alustoille
SG11201503660VA (en) Substrate supporting apparatus
BR112015004363A2 (pt) instalação de pulverização de produto de revestimento
DK2623215T3 (da) Hydrofile plasmaovertræk
SI2714415T1 (sl) Postopek za proizvodnjo premaznih substratov
FI20115400A (fi) Telapinnoite ja menetelmä sen valmistamiseksi
PL2765866T3 (pl) Nowy system powlekający
FI20125986A (fi) Menetelmä funktionaalisten kerrosten muodostamiseksi piisubstraateille
FI20115204A (fi) Menetelmä kemikaalien talteenottamiseksi
FI20126269A (fi) Menetelmä nanoselluloosakomposiitin valmistamiseksi
BR112015006244A2 (pt) substrato revestido
BR112013029918A2 (pt) sistema de revestimento
PL2807210T3 (pl) Powłoki folii
SG2014013718A (en) Process for removing substances from substrates
EP2914672A4 (en) METHODS OF COATING SUBSTRATES AND SUBSTRATES OBTAINED THEREFROM
DK2854765T3 (da) Farmaceutisk pemetrexed-opløsning
DE112011101987T8 (de) Pulverbeschichtungsverfahren
HUE055426T2 (hu) Szubsztrátum feldolgozó berendezés
FI20115047A0 (fi) Menetelmä kasviöljyjen muuntamiseksi
FI20135904A (fi) Menetelmä substraatin päällystämiseksi
FI20120381A (fi) Menetelmä metallien talteenottamiseksi
HK1218396A1 (zh) 用於基材的塗層

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NOVALDMEDICAL LTD OY

FG Patent granted

Ref document number: 126168

Country of ref document: FI

Kind code of ref document: B

PC Transfer of assignment of patent

Owner name: APPLIED MATERIALS INC.